Email This Article

Headlines & Perspectives
FDA Hurdle Hits Amylin, Alkermes (Update)
By Elizabeth Trotta
11/04/08 - 12:48 PM EST
Shares of the drugmakers tumble on news their application for long-acting version of the diabetes drug Byetta don't meet FDA requirements.
Recipient's Email Address(es)
(Separate multiple addresses with a comma)
Your Email Address
Send a copy to myself
Your Message (optional)

Privacy Policy

The information entered on this page will not be used to send unsolicited email and will not be sold to a 3rd party.

Dow Jones S&P 500 NASDAQ 10-Year Note
10,409.61 1,103.39 2,197.38 34.67
Oil *
72.46
UP
72.56
UP
7.45
UP
13.65
UP
0.44
10 Yr
3.47%
SPDR Gold
110.82
+0.70%
+0.68%
+0.63%
+1.29%
Data delayed 20 minutes

Brokerage Partners